BPL stock news
This page provides real-time market news, earnings updates, and company announcements related to BPL Limited (BPL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-15 06:49 IST
AtaiBeckley Inc. (ATAI) Gains Momentum With Promising BPL-003 Data and Strong Analyst Support
Finviz2026-02-13 12:15:06
Wall Street Bullish on AtaiBeckley (ATAI), Here's Why
Finviz2026-02-15 09:12:42
AtaiBeckley To Participate in Upcoming Investor Conferences
Finviz2026-02-17 12:03:43
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
Finviz2026-02-19 12:03:41
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
Finviz2026-02-26 12:03:46
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
Finviz2026-03-03 12:04:19
AtaiBeckley's BPL-003: Is It a Breakthrough for BTD or a Risky Investment?
101 finance2026-03-04 06:39:39
AtaiBeckley Inc (ATAI)'s Drug Candidate EMP-01 Shows Positive Results in Key Study
Finviz2026-03-04 10:42:44
AtaiBeckley (ATAI) to Initiate Phase 3 Depression Study Following Positive FDA Meeting
Finviz2026-03-04 16:42:47
AtaiBeckley (ATAI) Reports 2025 Results and Q2 2026 Phase 3 Launch for BPL-003
Finviz2026-03-08 17:00:58
After successfully completing the end-of-phase II meeting with the U.S. Food and Drug Administration (FDA), the phase III clinical trial plan for BPL-003 is progressing steadily and is expected to officially launch in the second quarter of 2026.
老虎证券2026-03-10 10:07:45
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
Finviz2026-02-26 12:03:46
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
Finviz2026-03-03 12:04:19
AtaiBeckley's BPL-003: Is It a Breakthrough for BTD or a Risky Investment?
101 finance2026-03-04 06:39:39
AtaiBeckley Inc (ATAI)'s Drug Candidate EMP-01 Shows Positive Results in Key Study
Finviz2026-03-04 10:42:44
AtaiBeckley (ATAI) to Initiate Phase 3 Depression Study Following Positive FDA Meeting
Finviz2026-03-04 16:42:47
AtaiBeckley (ATAI) Reports 2025 Results and Q2 2026 Phase 3 Launch for BPL-003
Finviz2026-03-08 17:00:58
After successfully completing the end-of-phase II meeting with the U.S. Food and Drug Administration (FDA), the phase III clinical trial plan for BPL-003 is progressing steadily and is expected to officially launch in the second quarter of 2026.
老虎证券2026-03-10 10:07:45
BPL stock price change
On the last trading day, BPL stock closed at 49.14 INR, with a price change of -3.99% for the day.
Trade stock perpsBPL stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more